AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE
Details
- Status
- Prescription
- First Approved
- 2017-04-28
- Routes
- NASAL
- Dosage Forms
- SPRAY, METERED
Companies
AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE Approval History
What AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE Treats
1 indicationsAZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE is approved for 1 conditions since its original approval in 2017. These indications span multiple therapeutic areas including oncology, immunology, and more.
- Seasonal Allergic Rhinitis
Drugs Similar to AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE
FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE FDA Label Details
ProIndications & Usage
Azelastine hydrochloride and fluticasone propionate nasal spray is indicated for the relief of symptoms of seasonal allergic rhinitis in adult and pediatric patients 6 years of age and older. Azelastine hydrochloride and fluticasone propionate nasal spray contains an H 1 -receptor antagonist and a corticosteroid, and is indicated for the relief of symptoms of seasonal allergic rhinitis in adult and pediatric patients 6 years of age and older.
Want competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.